Bigul

Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Dear Sir / Madam, Pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015, we wish to inform you that officials of the Company will be Meeting Investors (Participants) as per below schedule: Day & Date Monday, 26th September, 2022 Host Goldman Sachs: India Pharma and Healthcare Tour September 2022 Place Mumbai Meetings In Person Meetings + Virtual Meeting Discussions will be based on publicly available information. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions. Kindly note that changes may happen due to exigencies on the part of Participants / Host / Company. This is for your information and also for the information of your Members and the public at large.
26-09-2022
Bigul

Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Dear Sir / Madam, Pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015, we wish to inform you that officials of the Company will be Meeting Investors (Participants) as per below schedule: 12th & 13th September, 2022- IIFL Securities Singapore- In Person Meetings (Non-Deal Roadshow). Discussions will be based on publicly available information. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions. Kindly note that changes may happen due to exigencies on the part of Participants / Host / Company. This is for your information and also for the information of your Members and the public at large.
07-09-2022
Bigul

Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015, we wish to inform you that officials of the Company will be Meeting Investors (Participants) on September 7, 2022, conference hosted by Kotak Institutional Equities. This is to further inform that during the meeting, the Company will be referring to the Investor Presentation available on the website of the Company and issued to the Stock Exchanges on August 10, 2022.
01-09-2022
Bigul

Metropolis Healthcare Ltd - 542650 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

Metropolis Healthcare Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
18-08-2022
Bigul

Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Resignation of Chief Executive Officer (CEO)

This is in continuation of letter dated July 29,2022 bearing reference no. MHL/Sec&Legal/2022-23/41 wherein the Company intimated that Mr. Vijender Singh(CEO) has resigned from the position of the Chief Executive Officer of Metropolis Healthcare Limited and his last working day with the Company was till the Closure of business hours of Wednesday, November 30,2022. Pursuant to request of Mr. Vijender Singh his last working day with Company has been revised to August 17,2022 and his balance notice period has been waived off. Further, the Company has appointed a Talent Search Agency and has begun the process of finding a suitable candidate for the position of CEO.
18-08-2022
Bigul

Metropolis Healthcare Ltd - 542650 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

Dear Sir/Ma''am, Pursuant to Regulation 44 of the SEBI Listing Regulations and Section 108 of the Act read with Rules made thereunder, we enclose herewith the details of voting results along with the consolidated Scrutinizers' Report on remote e voting and e-voting.
18-08-2022
Bigul

Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

Dear Sir/ Madam, This is in continuation to our letter bearing reference No. MHL/Sec&Legal/2022-23/45 dated August 06, 2022, please find enclosed herewith copy of the transcript of the Earnings Call held on Thursday, August 11, 2022, wherein the Management of the Company discussed the Q1FY2023 Results. The same has also been uploaded on the Company's website and can be accessed at www.metropolisindia.com You are requested to take the above information on record.
17-08-2022
Bigul

Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Meeting Updates

Proceedings of 22nd Annual General Meeting of Metropolis Healthcare Limited
17-08-2022
Bigul

Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

This is in continuation to our letter bearing reference No: MHL/Sec&Legal/2022-23/45 dated August 06, 2022, with respect to intimation of Earnings Call for the quarter ended June 30, 2022 and pursuant to Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, the audio recording of the Earnings call held on August 11, 2022 to discuss the Q1FY23 Results of the Company, is available on the Company's website.
11-08-2022

Results Earnings Call for Q1FY23 of Metropolis Healthcare

Conference Call with Metropolis Healthcare Management and Analysts on Q1FY23 Performance and Outlook. Listen to the full earnings transcript.
11-08-2022
Next Page
Close

Let's Open Free Demat Account